This announcement is a separate document:
中智藥業：(1) 購回及發行股份之一般授權 (2) 建議自股份溢價賬派付末期股息及特別股息 (3) 重選董事 (4) 建議修訂組織章程大綱及細則及 採納經修訂及重訂之 組織章程大綱及細則 及 (5) 股東週年大會通告
ZHONGZHIPHARM: (1) GENERAL MANDATES TO REPURCHASE AND ISSUE SHARES (2) PROPOSED PAYMENT OF FINAL DIVIDEND AND SPECIAL DIVIDEND OUT OF SHARE PREMIUM ACCOUNT (3) RE-ELECTION OF DIRECTORS (4) PROPOSED AMENDMENTS TO THE MEMORANDUM AND ARTICLES OF ASSOCIATION A
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.